Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00519961
Status:
UNKNOWN
Last Update Posted:
2011-03-16
First Post:
2007-08-22
Brief Title:
A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide NT-proBNP for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Study Overview
Official Title:
A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide NT-proBNP for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery
Status:
UNKNOWN
Status Verified Date:
2011-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing All patients will have NT-proBNP concentrations measured pre-operatively For low-intermediate risk patients only those with abnormal values will receive further cardiac testing all high risk patients will be referred for additional testing
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DECREASE-VI | None | None | None |